YOLFTbeta
Thalia Therapeutics Plc

Thalia Therapeutics Plc

THAT · LSE · Healthcare / Biotechnology

0.575GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.575
Open0.535
Day Range0.50 – 0.60
52-Week Range0.40 – 0.95
Volume2.59M
Market Cap11.10M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.71
50-Day Avg0.629
200-Day Avg0.571

About

Thalia Therapeutics Plc, a biotechnology company, develops and delivers RNA-based therapeutics and technologies in oncology and cardiovascular disease in the United Kingdom. The company develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines. It also develops Nuvec, a pipeline of RNA therapeutics; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. The company has collaboration with the Centre for Continuous Manufacturing and Advanced Crystallisation at the University of Strathclyde to support the scale-up and characterisation of Nuvec. The company was formerly known as N4 Pharma Plc and changed its name to Thalia Therapeutics Plc in March 2026. Thalia Therapeutics Plc was incorporated in 1979 and is based in London, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. David Horn Solomon M.D.
  • Employees3
  • Headquarters2 Portman Street, London, United Kingdom, W1H 6DU, UK
  • Websitehttps://www.thaliatx.com

Leadership

  • Mr. Luke Sebastian CairnsExecutive Director · b. 1978
  • Dr. David Horn Solomon M.D.CEO & Executive Director · b. 1960
  • Rob HarrisHead of CMC Development
  • Dr. Fiona McLaughlin FSB, Ph.D.Head of Research & Development · b. 1970
  • Mr. Mark Edbrooke Ph.D.Head of Strategy
  • Dr. Margaret Courtney Ph.D.Head of Chemistry, Manufacturing & Controls
  • Dr. Andrew LeishmanConsultant

Financials

Income Statement

Currency: GBP1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue19.02M21.23M26.63M32.15M23.44M36.87M49.89M35.17M44.15M55.05M65.18M38.60M14.44M12.54M6.95M4.39M2.03M1.77M1.66M1.07M1.40M1.56M1.98M1.87M1.92M2.97M2.68M2.26M1.36M-1.16M----001.95K7.28K7.26K
Growth (%)-+11.61%+25.42%+20.71%-27.07%+57.28%+35.30%-29.50%+25.52%+24.70%+18.39%-40.78%-62.60%-13.13%-44.57%-36.84%-53.86%-12.64%-6.27%-35.26%+30.17%+11.87%+26.41%-5.56%+2.79%+54.77%-9.83%-15.57%-39.67%---------+272.86%-0.25%
Cost of Revenue-----------30.72M12.26M8.20M4.42M2.53M672.00K657.00K544.00K327.00K372.00K452.00K648.00K713.00K761.00K1.67M1.50M1.19M545.00K-934.00K---------
Gross Profit19.02M21.23M26.63M32.15M23.44M36.87M49.89M35.17M44.15M55.05M65.18M7.88M2.18M4.34M2.54M1.86M1.35M1.11M1.11M747.00K1.03M1.11M1.33M1.15M1.16M1.30M1.18M1.07M819.00K-221.00K------1.95K7.28K7.26K
Gross Margin100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%20.42%15.10%34.59%36.48%42.31%66.83%62.88%67.21%69.55%73.39%71.10%67.22%61.81%60.34%43.94%43.91%47.55%60.04%-19.13%------100.00%100.00%100.00%
Operating Expense17.81M19.76M24.80M30.74M25.66M39.40M48.67M32.98M41.41M51.45M65.76M9.31M6.53M4.78M2.92M1.01M1.22M898.00K843.00K1.08M985.00K879.00K1.10M933.00K802.00K819.00K1.09M1.12M2.54M-249.00K------1.43M1.23M1.11M
Operating Income1.22M1.47M1.83M1.41M-2.22M-2.52M1.21M2.19M2.74M3.60M-586.00K-1.43M-4.35M-443.00K-381.00K843.00K131.00K215.00K272.00K-331.00K41.00K233.00K232.00K221.00K356.00K486.00K81.00K-47.00K-1.73M-160.00K-28.00K-726.00K-1.49M-947.00K-1.56M-1.84M-1.19M-1.43M-1.22M-1.10M
Operating Margin6.39%6.94%6.87%4.37%-9.47%-6.85%2.43%6.22%6.20%6.53%-0.90%-3.71%-30.13%-3.53%-5.48%19.20%6.47%12.15%16.40%-30.82%2.93%14.90%11.73%11.84%18.55%16.36%3.02%-2.08%-126.54%--2.42%-------72964.67%-16767.37%-15199.56%
EBITDA1.66M2.03M2.44M2.18M-1.34M-1.82M205.00K2.77M3.80M5.43M3.52M-10.44M-4.05M-63.00K58.00K945.00K464.00K489.00K608.00K-797.00K242.00K313.00K268.00K403.00K686.00K288.00K-14.00K13.00K70.00K-185.08K-1.92M-1.42M-947.00K-1.56M-1.84M-1.19M-1.33M-1.22M-1.10M
EBITDA Margin8.74%9.58%9.15%6.77%-5.73%-4.94%0.41%7.88%8.60%9.87%5.39%-27.06%-28.03%-0.50%0.83%21.52%22.90%27.63%36.65%-57.01%15.47%15.83%14.35%21.00%23.10%10.75%-0.62%0.95%--16.02%-------68356.37%-16767.37%-15199.56%
Net Income726.00K949.00K1.14M848.00K-1.72M-2.61M-2.13M1.31M1.96M2.31M160.00K-13.01M-4.96M-783.00K-783.00K576.00K201.00K169.00K285.00K-400.00K515.00K265.00K260.00K214.00K364.00K517.00K136.00K-156.00K-2.39M-1.05M-22.00K-1.84M-1.19M-876.00K-1.30M-1.54M-1.03M-1.27M-1.06M-1.21M
Net Income Margin3.82%4.47%4.27%2.64%-7.35%-7.07%-4.28%3.72%4.44%4.21%0.25%-33.71%-34.38%-6.24%-11.26%13.12%9.92%9.55%17.18%-37.24%36.84%16.94%13.15%11.46%18.97%17.41%5.08%-6.90%-175.51%--1.90%-------64976.96%-14542.71%-16589.87%
R&D441.00K648.00K698.00K1.15M984.00K681.00K862.00K1.11M1.89M2.11M3.06M1.42M1.42M752.00K703.00K404.00K92.00K94.00K108.00K50.00K89.00K----------409.81K846.18K216.95K900.41K1.18M577.52K619.39K390.39K91.87K
R&D as % of Total Revenue2.32%3.05%2.62%3.58%4.20%1.85%1.73%3.15%4.27%3.84%4.69%3.68%9.86%6.00%10.11%9.20%4.54%5.31%6.51%4.66%6.37%----------------31714.90%5360.99%1264.73%
Interest Expense64.00K62.00K66.00K129.00K196.00K747.00K923.00K342.00K300.00K501.00K744.00K884.00K627.00K340.00K402.00K281.00K219.00K205.00K206.00K210.00K150.00K--7.00K3.00K3.00K10.00K6.00K5.00K4.00K5.86K5.30K9811.39K1.96K-----
Interest Expense % of Total Revenue0.34%0.29%0.25%0.40%0.84%2.03%1.85%0.97%0.68%0.91%1.14%2.29%4.34%2.71%5.78%6.40%10.81%11.58%12.42%19.55%10.73%--0.37%0.16%0.10%0.37%0.27%0.37%-0.51%---------

Balance Sheet

Currency: GBP1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.63M14.58M16.29M18.29M15.85M29.38M25.25M20.40M29.35M37.42M34.48M27.20M7.34M5.56M4.04M4.04M3.92M3.93M4.90M4.26M1.41M1.70M1.98M3.79M3.99M4.96M4.85M4.35M1.85M658.00K1.12M1.46M1.07M1.07M3.83M2.34M2.17M1.28M775.77K1.17M
Total Liabilities4.70M6.11M7.16M7.21M6.20M20.05M18.22M12.14M18.88M25.21M23.55M26.17M10.10M8.73M8.03M5.21M4.85M4.71M4.07M3.87M509.00K530.00K554.00K1.16M1.04M1.47M1.24M902.00K807.00K17.00K77.00K179.22K190.12K77.68K169.08K212.73K77.89K81.73K124.37K97.96K
Total Equity7.93M8.47M9.13M11.09M9.64M9.33M7.03M8.26M10.48M12.21M10.93M1.03M-2.76M-3.17M-3.99M-6.67M-6.44M-6.30M791.00K388.00K903.00K1.17M1.43M2.63M2.96M3.49M3.60M3.45M1.04M641.00K1.04M1.28M879.94K987.34K3.66M2.13M2.09M1.13M647.65K1.07M
Cash615.00K1.00M848.00K1.97M307.00K309.00K795.00K583.00K3.42M3.96M2.13M2.56M621.00K307.00K554.00K74.00K99.00K85.00K237.00K4.00K832.00K1.03M122.00K886.00K663.00K388.00K237.00K185.00K347.00K587.00K172.00K1.33M793.14K965.75K3.56M1.78M1.92M1.03M625.97K1.08M
Total Debt499.00K607.00K794.00K1.63M1.59M8.16M6.58M4.56M6.39M10.97M11.32M11.46M4.21M3.62M4.38M2.90M3.67M3.45M3.33M3.25M---155.00K116.00K405.00K140.00K182.00K294.00K-204.92K---------
Net Debt-116.00K-398.00K-54.00K-340.00K1.28M7.86M5.78M3.98M2.97M7.00M9.19M8.90M3.59M3.31M3.83M2.83M3.57M3.36M3.09M3.25M-832.00K-1.03M-122.00K-731.00K-547.00K17.00K-97.00K-3.00K-53.00K-587.00K32.92K-1.33M-793.14K-965.75K-3.56M-1.78M-1.92M-1.03M-625.97K-1.08M

Cash Flow

Currency: GBP1991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.42M2.72M310.00K3.34M163.00K2.02M-2.66M-2.72M-171.00K-380.00K210.00K-739.00K85.00K140.00K-113.00K-67.00K160.00K-184.00K755.00K249.00K996.00K-324.00K-87.00K-340.00K-862.00K-376.00K-950.80K-1.34M-806.00K-1.38M-1.77M-828.26K-1.21M-971.50K-1.16M
Investing Cash Flow-6.22M-551.00K1.52M-2.56M-4.19M-4.42M2.98M3.14M23.00K-136.00K15.00K-1.00K121.00K-63.00K-53.00K4.15M34.00K-720.00K-935.00K-472.00K-1.31M183.00K41.00K507.00K1.11M-39.00K402.99K27.69K----781--
Financing Cash Flow2.32M-255.00K1.40M695.00K305.00K2.79M-252.00K676.00K908.00K-57.00K-84.00K765.00K-220.00K75.00K-251.00K-3.07M--944.00K-42.00K-10.00K-6.00K-5.00K-4.00K119.92K1.85M783.42K978.62K3.97M677963.77K315.90K570.36K1.61M
Capital Expenditure637.00K631.00K824.00K2.73M3.93M3.67M1.58M64.00K74.00K152.00K18.00K1.00K131.00K63.00K8.00K27.00K9.00K592.00K928.00K469.00K1.31M239.00K216.00K000000003005
Free Cash Flow-3.06M2.09M-514.00K601.00K-3.76M-1.65M-4.24M-2.79M-245.00K-532.00K192.00K-740.00K-46.00K77.00K-121.00K-94.00K151.00K-776.00K-173.00K-220.00K-314.00K-563.00K-303.00K-340.00K-862.00K-376.00K-950.80K-1.34M-806.00K-1.38M-1.77M-828.26K-1.21M-971.50K-1.16M
FCF to OCF126.30%76.82%-165.81%18.02%-2308.59%-81.86%159.59%102.35%143.27%140.00%91.43%100.14%-54.12%55.00%107.08%140.30%94.38%421.74%-22.91%-88.35%-31.53%173.77%348.28%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%

Key Statistics & Ratios

Market Cap11.10M
Enterprise Value9.13M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1538.01
Price / Book9.54
EPS0.00
Book Value0.001
Revenue (TTM)7.22K
Gross Profit (TTM)7.22K
Profit Margin0.00%
Operating Margin-20790.56%
Return on Equity-69.25%
Return on Assets-39.88%
Shares Outstanding1.78B
Shares Float713.81M
Beta0.71
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19971×
0.18May 19, 1997
19962×
0.17Nov 4, 19960.18Jun 3, 1996
19952×
0.16Nov 6, 19950.16May 22, 1995

Stock Splits

  • May 3, 2017200:800
  • Oct 15, 20151:10